Avalo Therapeutics (AVTX) Net Margin Growth (1y) (2017 - 2025)
Avalo Therapeutics (AVTX) Net Margin Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -484,851.00 |
| Dec 31, 2024 | -1.70 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Dec 31, 2021 | -6,301.00 |
| Sep 30, 2021 | 2,345.00 |
| Jun 30, 2021 | 3,606.00 |
| Mar 31, 2021 | -6,010.00 |
| Dec 31, 2020 | -14,994.00 |
| Sep 30, 2020 | 3,151.00 |
| Jun 30, 2020 | 22,877.00 |
| Mar 31, 2020 | 12,664.00 |
| Dec 31, 2019 | 17,092.00 |
| Sep 30, 2019 | 55,443.00 |
| Jun 30, 2019 | -13,723.00 |
| Mar 31, 2019 | -233.00 |
| Dec 31, 2018 | 17,414.00 |
| Sep 30, 2018 | -67,854.00 |
| Jun 30, 2018 | 101,420.00 |
| Mar 31, 2018 | 42,369.00 |
| Dec 31, 2017 | 73,861.00 |